Cargando…
Polymorphisms of cytochrome P450 are potential candidates that could potentially help clinicians on the treatment of cardiovascular diseases among Asian populations
There are significant ethnic differences in the metabolism of some drugs that can be explained by cytochrome P450 polymorphisms and, in particular, the CYP2D6 isozyme. In addition, among patients who are not carriers of the CYP2C19 loss-of-function alleles, there is a reduced risk of stroke when clo...
Autor principal: | Daniel, López-Hernández |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650582/ https://www.ncbi.nlm.nih.gov/pubmed/29054193 http://dx.doi.org/10.1016/j.ihj.2017.02.016 |
Ejemplares similares
-
In vitro assessment of cytochrome P450 inhibition and induction potential of azacitidine
por: Chen, Yong, et al.
Publicado: (2010) -
Polymorphism of the cytochrome P-450 1A1 (A2455G) in women with breast cancer in Eastern Azerbaijan, Iran
por: Saadatian, Hakimeh, et al.
Publicado: (2014) -
Effect of Coleus forskohlii and its major constituents on cytochrome P450 induction
por: Hebbani Nagarajappa, Shivaprasad, et al.
Publicado: (2015) -
Role of cytochrome P450 for vitamin D metabolisms in patients with neurodegenerative disorders
por: Kakimoto, Asako, et al.
Publicado: (2022) -
The FMN “140s Loop” of Cytochrome P450 Reductase Controls Electron Transfer to Cytochrome P450
por: Rwere, Freeborn, et al.
Publicado: (2021)